Gemcitabine, Docetaxel a Viable Alternative to BCG in Bladder Cancer
MONDAY, March 13, 2023 (HealthDay News) — For patients with non-muscle invasive bladder cancer (NMIBC), gemcitabine and docetaxel therapy is associated with less high-grade disease recurrence, according to a study published online Feb. 28 in JAMA Net…
Learn MoreRemdesivir Beneficial for Subgroup Hospitalized With COVID-19
MONDAY, March 13, 2023 (HealthDay News) — For patients hospitalized with COVID-19, remdesivir is associated with reduced mortality among those receiving no or low-flow oxygen, according to a review published online Feb. 21 in The Lancet Respiratory M…
Learn MoreBenefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 (HealthDay News) — For patients with advanced renal cell carcinoma, progression-free survival and overall survival are improved with lenvatinib plus pembrolizumab versus sunitinib, according to a study published in the March is…
Learn MoreNew Nasal Spray for Migraines Approved by FDA
MONDAY, March 13, 2023 (HealthDay News) – Migraine sufferers will soon have a new treatment option that works more quickly and may be safer for people at risk of heart attack or stroke. The U.S. Food and Drug Administration has approved Pfizer Inc.’s …
Learn MoreACC: Sotatercept Boosts Exercise Capacity With Pulmonary Arterial Hypertension
FRIDAY, March 10, 2023 (HealthDay News) — Sotatercept is associated with a greater improvement in exercise capacity than placebo among patients with pulmonary arterial hypertension (PAH) receiving stable background therapy, according to a study publi…
Learn MoreFor Seniors on Antidepressants, Adding a Drug May Work Better Than Switching
FRIDAY, March 10, 2023 (HealthDay News) — Many older adults with depression don’t respond to their first antidepressant, so doctors will switch them to another one to see if that does the trick.Now, new research suggests that the best strategy for t…
Learn MoreShorter Primary Care Visit Length Linked to Inappropriate Prescribing
FRIDAY, March 10, 2023 (HealthDay News) — For patients with primary care visits, shorter visit length is associated with potentially inappropriate prescribing decisions, according to a study published online March 10 in JAMA Health Forum.Hannah T. Ne…
Learn MoreFDA Expands Indication for Use of Abemaciclib With Early, High-Risk Breast Cancer
FRIDAY, March 10, 2023 (HealthDay News) — Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor r…
Learn MoreHydrochlorothiazide Does Not Affect Recurrence of Kidney Stones
FRIDAY, March 10, 2023 (HealthDay News) — Hydrochlorothiazide does not reduce the risk for recurrence among patients with recurrent kidney stones, according to a study published in the March 2 issue of the New England Journal of Medicine.Nasser A. Dh…
Learn MoreViral, Symptom Rebound Common After COVID-19 Infection
THURSDAY, March 9, 2023 (HealthDay News) — COVID-19 rebound is common, even among patients treated with nirmatrelvir plus ritonavir (NPR), according to a study published online Feb. 22 in Clinical Infectious Diseases.Jay A. Pandit, M.D., from the Scr…
Learn More